Avalon GloboCare Corp. (NASDAQ:ALBT) Sees Large Growth in Short Interest

Avalon GloboCare Corp. (NASDAQ:ALBT) was the target of a significant growth in short interest in December. As of December 15th, there was short interest totalling 114,200 shares, a growth of 275.7% from the November 30th total of 30,400 shares. Based on an average trading volume of 1,420,000 shares, the short-interest ratio is presently 0.1 days. Currently, 27.0% of the shares of the company are short sold.

Avalon GloboCare Stock Performance

Shares of ALBT stock traded down $0.26 on Friday, hitting $3.29. The company’s stock had a trading volume of 243,566 shares, compared to its average volume of 497,828. The stock’s 50 day moving average is $3.25 and its 200-day moving average is $4.44. Avalon GloboCare has a fifty-two week low of $2.11 and a fifty-two week high of $21.60. The company has a market capitalization of $3.60 million, a PE ratio of -0.16 and a beta of 0.27.

Avalon GloboCare Company Profile

Avalon GloboCare Corp., together with its subsidiaries, owns and operates commercial real estate properties in the United States and China. The company develops and delivers transformative cellular therapeutics, precision diagnostics, and clinical laboratory services. Its leading candidates are AVA-001, an anti-CD19 CAR-T, which has completed first-in-human clinical trial for relapsed/refractory (R/R) B-cell lymphoblastic leukemia; and AVA-011 that has completed pre-clinical laboratory studies and undergoing IND-enabling process development stage to generate cGMP-grade AVA-011 CAR-T cells.